ArticleThe oncologist2026

Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program.

Anne O'Hagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.